Acura Pharmaceuticals, Inc. (ACUR)
USD 0.02
(1000.0%)
USD 0.02
(1000.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -742 Thousand | -719 Thousand | -618 Thousand | -3.9 Million | -4.51 Million |
| Net Income | - | -879 Thousand | -1.2 Million | -3.77 Million | -3.84 Million | -5.68 Million |
| Depreciation & Amortization | - | 90 Thousand | 125 Thousand | 273 Thousand | 280 Thousand | 294 Thousand |
| Deferred income taxes | - | - | - | 2.6 Million | -296 Thousand | 47 Thousand |
| Stock-based compensation | - | 58 Thousand | 36 Thousand | 108 Thousand | 218 Thousand | 464 Thousand |
| Change in working capital | - | 477 Thousand | -340 Thousand | 121 Thousand | -183 Thousand | 268 Thousand |
| Other non-cash items | - | -488 Thousand | 668 Thousand | 53 Thousand | -85 Thousand | 99 Thousand |
| Investing Cash Flow | - | - | - | - | - | 309 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | 103 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 309 Thousand |
| Financing Cash Flow | - | 394 Thousand | 270 Thousand | 1.38 Million | 1.77 Million | 1.24 Million |
| Debt repayment | - | -17 Thousand | -269 Thousand | -1.37 Million | -2.57 Million | -2.76 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -8.00 | -2.00 | - | - | - |
| Common Stock Issuance | - | 3000.00 | 3000.00 | 14 Thousand | 2000.00 | 4 Million |
| Other Financing Activities | - | 408 Thousand | 536 Thousand | 14 Thousand | 4.35 Million | 4000.00 |
| Accounts receivables | - | 469 Thousand | -399 Thousand | 44 Thousand | -66 Thousand | 23 Thousand |
| Accounts payables | - | 161 Thousand | -206 Thousand | -368 Thousand | 602 Thousand | -74 Thousand |
| Inventory | - | -469 Thousand | 399 Thousand | -44 Thousand | - | 103 Thousand |
| Other working capital | - | 316 Thousand | -134 Thousand | 489 Thousand | -785 Thousand | 216 Thousand |
| Cash at beginning of period | 65 Thousand | 413 Thousand | 862 Thousand | 91 Thousand | 2.22 Million | 5.18 Million |
| Cash at end of period | 65 Thousand | 65 Thousand | 413 Thousand | 862 Thousand | 91 Thousand | 2.22 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -348 Thousand | -449 Thousand | 771 Thousand | -2.12 Million | -2.96 Million |
| Free Cash Flow | - | -742 Thousand | -719 Thousand | -618 Thousand | -3.9 Million | -4.51 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | - | 65 Thousand | - |
| Cash at end of period | - | - | - | - | 65 Thousand | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
CBGL
CBAF
PHOT
BNXA
9990
2509